Finally, a solution to address specialty pharmacy costs.

Ethicos Health offers a clinical guidance administration platform for specialty pharmacy.

Plan sponsors have had no independent, transparent, clinically-validated platform to manage specialty pharmacy and complex therapy costs.

Until Now.

Specialty pharmacy medications, including GLP-1s, can be life-changing therapies at the forefront of medicine.

They can also be very expensive, often ineffective and potentially harmful.

Very expensive

In 2023, the average cost of specialty pharmacy medication was
$84,000 / course.

In 2027, with the introduction of new cell and gene therapies, the cost will grow to
$2,500,000 / course.

Often ineffective

Many specialty medications have been pulled from the market due to ineffectiveness.

Others continue to be prescribed even though the drug is not effective as measured by intended clinical endpoints.

Potentially harmful

36.7% of older patients are prescribed potentially inappropriate medications.

Introducing

The Ethicos Health Clinical Guideline Administration Platform

The first independent, transparent, clinically-validated platform to manage specialty pharmacy and complex therapy costs.

  • Enables better and safer care for patients

  • Provides better patient and provider experience by replacing prior authorization with proactive clinical guidance

  • Supports providers by enabling data-driven, high value care

  • Improves quality while reducing cost for plan sponsors and their members

  • Helps plan sponsors remain compliant with ERISA fiduciary and CMS regulatory requirements

Let us power your specialty pharmacy management program

Our AI-enabled platform provides clarity and transparency to the field of specialty pharmaceutical and complex therapies to manage your specialty pharmacy program in a data-driven and high-value manner.